Jessica M. Fogel

机构：Johns Hopkins University, Johns Hopkins Medicine · ORCID：0000-0003-3143-9000

发表论文 63 篇 · 总被引 1318 次 · h-index 21

代表论文

• PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial (2021 · PLoS Medicine · 被引 181)
• Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 (2021 · The Journal of Infectious Diseases · 被引 133)
• Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084 (2021 · The Journal of Infectious Diseases · 被引 70)
• Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis (2024 · New England Journal of Medicine · 被引 37)
• HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention (2022 · The Journal of Infectious Diseases · 被引 37)
• Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 (2023 · Antimicrobial Agents and Chemotherapy · 被引 30)